216 related articles for article (PubMed ID: 22056652)
1. Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases.
Fujio Y; Maeda M; Mohri T; Obana M; Iwakura T; Hayama A; Yamashita T; Nakayama H; Azuma J
J Pharmacol Sci; 2011; 117(4):213-22. PubMed ID: 22056652
[TBL] [Abstract][Full Text] [Related]
2. Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling.
Dittrich A; Quaiser T; Khouri C; Görtz D; Mönnigmann M; Schaper F
Mol Biosyst; 2012 Aug; 8(8):2119-34. PubMed ID: 22711165
[TBL] [Abstract][Full Text] [Related]
3. Remote Ischemic Preconditioning induces Cardioprotective Autophagy and Signals through the IL-6-Dependent JAK-STAT Pathway.
Billah M; Ridiandries A; Allahwala UK; Mudaliar H; Dona A; Hunyor S; Khachigian LM; Bhindi R
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121587
[No Abstract] [Full Text] [Related]
4. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.
Fischer P; Hilfiker-Kleiner D
Basic Res Cardiol; 2007 Jul; 102(4):279-97. PubMed ID: 17530315
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
6. Exercise rescued chronic kidney disease by attenuating cardiac hypertrophy through the cardiotrophin-1 -> LIFR/gp 130 -> JAK/STAT3 pathway.
Chen KC; Hsieh CL; Peng CC; Peng RY
Eur J Prev Cardiol; 2014 Apr; 21(4):507-20. PubMed ID: 23064267
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of N-glycosylation of glycoprotein 130 molecule abolishes STAT3 activation by IL-6 family cytokines in cultured cardiac myocytes.
Matsuo R; Morihara H; Mohri T; Murasawa S; Takewaki K; Nakayama H; Maeda M; Fujio Y
PLoS One; 2014; 9(10):e111097. PubMed ID: 25340554
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
[TBL] [Abstract][Full Text] [Related]
9. Regulation of IL-6-type cytokine responses by MAPKs.
Costa-Pereira AP
Biochem Soc Trans; 2014 Feb; 42(1):59-62. PubMed ID: 24450628
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
Himpe E; Kooijman R
Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
[TBL] [Abstract][Full Text] [Related]
11. Dynamics and non-canonical aspects of JAK/STAT signalling.
Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
[TBL] [Abstract][Full Text] [Related]
12. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
13. Targeting the gp130/STAT3 Axis Attenuates Tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma Cells.
Sreenivasan L; Li LV; Leclair P; Lim CJ
Cells; 2022 Jan; 11(3):. PubMed ID: 35159191
[TBL] [Abstract][Full Text] [Related]
14. NDP-α-MSH attenuates heart and liver responses to myocardial reperfusion via the vagus nerve and JAK/ERK/STAT signaling.
Ottani A; Giuliani D; Neri L; Calevro A; Canalini F; Vandini E; Cainazzo MM; Ruberto IA; Barbieri A; Rossi R; Guarini S
Eur J Pharmacol; 2015 Dec; 769():22-32. PubMed ID: 26477637
[TBL] [Abstract][Full Text] [Related]
15. Cardiac overexpression of Epac1 in transgenic mice rescues lipopolysaccharide-induced cardiac dysfunction and inhibits Jak-STAT pathway.
Jin H; Fujita T; Jin M; Kurotani R; Namekata I; Hamaguchi S; Hidaka Y; Cai W; Suita K; Ohnuki Y; Mototani Y; Shiozawa K; Prajapati R; Liang C; Umemura M; Yokoyama U; Sato M; Tanaka H; Okumura S; Ishikawa Y
J Mol Cell Cardiol; 2017 Jul; 108():170-180. PubMed ID: 28629760
[TBL] [Abstract][Full Text] [Related]
16. GP130 signaling and the control of naïve pluripotency in humans, monkeys, and pigs.
Bourillot PY; Santamaria C; David L; Savatier P
Exp Cell Res; 2020 Jan; 386(1):111712. PubMed ID: 31697928
[TBL] [Abstract][Full Text] [Related]
17. Activating mutations of the gp130/JAK/STAT pathway in human diseases.
Lokau J; Garbers C
Adv Protein Chem Struct Biol; 2019; 116():283-309. PubMed ID: 31036294
[TBL] [Abstract][Full Text] [Related]
18. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.
Tao W; Wen F; Zhang H; Liu G
Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729
[TBL] [Abstract][Full Text] [Related]
19. Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling.
Kurdi M; Booz GW
J Cardiovasc Pharmacol; 2007 Aug; 50(2):126-41. PubMed ID: 17703129
[TBL] [Abstract][Full Text] [Related]
20. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
Kunisada K; Hirota H; Fujio Y; Matsui H; Tani Y; Yamauchi-Takihara K; Kishimoto T
Circulation; 1996 Nov; 94(10):2626-32. PubMed ID: 8921810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
